Published in J Nucl Med on March 01, 1995
Somatostatin receptor SPECT. Eur J Nucl Med Mol Imaging (2012) 0.91
Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor. J Clin Invest (1997) 0.89
SPECT and PET imaging of meningiomas. ScientificWorldJournal (2012) 0.82
Permeability of porcine blood brain barrier to somatostatin analogues. Br J Pharmacol (2002) 0.80
Somatostatin receptor subtype 2 in high-grade gliomas: PET/CT with (68)Ga-DOTA-peptides, correlation to prognostic markers, and implications for targeted radiotherapy. EJNMMI Res (2015) 0.75
Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med (1993) 3.45
Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use. Eur J Nucl Med (2000) 3.26
Somatostatin-receptor imaging in the localization of endocrine tumors. N Engl J Med (1990) 2.85
Prognostic classification of breast ductal carcinoma-in-situ. Lancet (1995) 2.70
Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology (2005) 2.49
Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands. Eur J Nucl Med (2001) 2.41
Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation (1998) 2.27
The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev (1991) 2.20
Mechanism for transition from initial to stable cell-cell adhesion: kinetic analysis of E-cadherin-mediated adhesion using a quantitative adhesion assay. J Cell Biol (1996) 2.20
Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis (2001) 1.94
Somatostatin receptor scintigraphy: its value in tumor localization in patients with Cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion. Am J Med (1994) 1.93
Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation. Cancer Res (1999) 1.92
Somatostatin receptors in human endocrine tumors. Cancer Res (1987) 1.77
Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin. Lancet (1989) 1.76
Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. Cancer Res (1990) 1.72
Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals? Eur J Nucl Med Mol Imaging (2007) 1.72
Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization, and therapy. J Clin Endocrinol Metab (1990) 1.71
Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation (1997) 1.67
Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors. Cancer Res (1997) 1.64
Somatostatin-receptor scintigraphy in primary breast cancer. Lancet (1994) 1.63
Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth. Gastroenterology (1991) 1.57
Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide. J Nucl Med (1992) 1.54
Potent and long-acting corticotropin releasing factor (CRF) receptor 2 selective peptide competitive antagonists. J Med Chem (2002) 1.53
Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization. Cancer Res (1994) 1.53
Evaluation of a radiolabeled somatostatin analog (I-123 octreotide) in the detection and localization of carcinoid and islet cell tumors. Radiology (1993) 1.52
Positron emission tomography and ultrasonography. A comparative retrospective study assessing the diagnostic validity in lymph node metastases of malignant melanoma. Arch Dermatol (1995) 1.50
Ace/Fgf8 is required for forebrain commissure formation and patterning of the telencephalon. Development (2000) 1.50
Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer (1995) 1.41
In vivo use of a radioiodinated somatostatin analogue: dynamics, metabolism, and binding to somatostatin receptor-positive tumors in man. J Nucl Med (1991) 1.41
[Chronic anemia and abdominal pain as a sequela of lead poisoning]. Dtsch Med Wochenschr (2001) 1.38
Dependency of blood flow velocity in the middle cerebral artery on end-tidal carbon dioxide partial pressure--a transcranial ultrasound Doppler study. J Cereb Blood Flow Metab (1984) 1.35
Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer. Cancer Res (1989) 1.32
Extended anterior subcranial approach for skull base tumors: long-term results. J Neurosurg (1995) 1.32
Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin. Cancer Res (2000) 1.29
Substance-P receptors in human primary neoplasms: tumoral and vascular localization. Int J Cancer (1995) 1.28
Identification and validation of P311 as a glioblastoma invasion gene using laser capture microdissection. Cancer Res (2001) 1.28
Isolated infarcts of the pons. Neurology (1996) 1.25
The role of dipeptidyl peptidase IV in human T lymphocyte activation. Inhibitors and antibodies against dipeptidyl peptidase IV suppress lymphocyte proliferation and immunoglobulin synthesis in vitro. Eur J Immunol (1987) 1.24
Chemistry and pharmacology of SMS 201-995, a long-acting octapeptide analogue of somatostatin. Scand J Gastroenterol Suppl (1986) 1.24
A clinical physiologic study of hydroxyethyl starch. Surg Gynecol Obstet (1970) 1.22
Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2. Gut (1996) 1.22
Regulatory peptide receptors in human hepatocellular carcinomas. Gut (1999) 1.22
Changes of circulating thyroxine, triiodothyronine and reverse triiodothyronine after radiographic contrast agents. J Clin Endocrinol Metab (1976) 1.18
Glutamate and non-glutamate receptor mediated toxicity caused by oxygen and glucose deprivation in organotypic hippocampal cultures. J Neurosci (1995) 1.16
Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast. Am J Pathol (1999) 1.15
High incidence of somatostatin receptors in human meningiomas: biochemical characterization. J Clin Endocrinol Metab (1986) 1.13
Preferential location of somatostatin receptors in germinal centers of human gut lymphoid tissue. Gastroenterology (1992) 1.13
Y(1)-mediated effect of neuropeptide Y in cancer: breast carcinomas as targets. Cancer Res (2001) 1.13
Death-associated protein 3 (Dap-3) is overexpressed in invasive glioblastoma cells in vivo and in glioma cell lines with induced motility phenotype in vitro. Clin Cancer Res (2001) 1.13
Reaction-induced infrared difference spectroscopy for the study of protein reaction mechanisms. Biochemistry (2001) 1.12
PET imaging of somatostatin receptors: design, synthesis and preclinical evaluation of a novel 18F-labelled, carbohydrated analogue of octreotide. Eur J Nucl Med Mol Imaging (2002) 1.10
Stress and the menstrual cycle: relevance of cycle quality in the short- and long-term response to a 5-day endotoxin challenge during the follicular phase in the rhesus monkey. J Clin Endocrinol Metab (1998) 1.10
Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma. Gut (1998) 1.09
[Studies on the purification and characterization of dipeptidyl aminopeptidase IV]. Acta Biol Med Ger (1974) 1.08
Neurotensin receptor-1 mRNA analysis in normal pancreas and pancreatic disease. Clin Cancer Res (2000) 1.08
Torsades de pointes during low-dosage sotalol therapy in haemodialysis patients. Nephrol Dial Transplant (1996) 1.08
Dopamine selectively increases 3H-GABA release from slices of rat substantia nigra in vitro. Nature (1977) 1.08
Somatostatin analogue scintigraphy in granulomatous diseases. Eur J Nucl Med (1994) 1.07
Pathogen frequency and resistance patterns in Brazilian hospitals: summary of results from three years of the SENTRY Antimicrobial Surveillance Program. Braz J Infect Dis (2003) 1.06
Effects of cerebral perfusion pressure and increased fraction of inspired oxygen on brain tissue oxygen, lactate and glucose in patients with severe head injury. Acta Neurochir (Wien) (2003) 1.05
Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trial. Eur J Nucl Med Mol Imaging (2010) 1.05
Supratentorial intracerebral hemorrhage after posterior fossa operation. Neurosurgery (1986) 1.04
Somatostatin receptors in human prostate and prostate cancer. J Clin Endocrinol Metab (1995) 1.04
Immunohistochemical localization of somatostatin receptors sst2A in human tumors. Am J Pathol (1998) 1.04
In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats. Life Sci (1991) 1.04
Somatostatin and the immune and haematopoetic system; a review. Eur J Clin Invest (1994) 1.04
Localization and characterization of neuropeptide receptors in human colon. Naunyn Schmiedebergs Arch Pharmacol (2001) 1.03
Somatostatin-receptor scintigraphy in gastroenteropancreatic tumors. An overview of European results. Ann N Y Acad Sci (1994) 1.03
Glucagon-like peptide-1 (GLP-1) receptors are not overexpressed in pancreatic islets from patients with severe hyperinsulinaemic hypoglycaemia following gastric bypass. Diabetologia (2010) 1.02
Estrogen and progesterone receptors in meningiomas in relation to clinical and pathologic features. Surg Neurol (1983) 1.02
Unexpected high incidence of cholecystokinin-B/gastrin receptors in human medullary thyroid carcinomas. Int J Cancer (1996) 1.01
P(3)-[2-(4-hydroxyphenyl)-2-oxo]ethyl ATP for the rapid activation of the Na(+),K(+)-ATPase. Biophys J (2000) 1.01
High affinity binding sites for a somatostatin-28 analog in rat brain. Life Sci (1981) 1.00
Noninvasive dopamine determination by reversed phase HPLC in the medium of free-floating roller tube cultures of rat fetal ventral mesencephalon: a tool to assess dopaminergic tissue prior to grafting. Brain Res Bull (1996) 1.00
Imaging tumors with peptide-based radioligands. Q J Nucl Med (2001) 1.00
Metastatic carcinoid tumors and the malignant carcinoid syndrome. Acta Oncol (1993) 0.99
Expression of somatostatin receptors in normal, inflamed, and neoplastic human gastrointestinal tissues. Ann N Y Acad Sci (1994) 0.99
Novel 111In-labelled bombesin analogues for molecular imaging of prostate tumours. Eur J Nucl Med Mol Imaging (2007) 0.99
Chronic subdural hematomas: to drain or not to drain? Neurosurgery (1985) 0.99
Measles outbreak in an asylum-seekers' shelter in Germany: comparison of the implemented with a hypothetical containment strategy. Epidemiol Infect (2011) 0.98
Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer. Eur J Nucl Med Mol Imaging (2003) 0.98
Cerebral vasospasm evaluated by transcranial ultrasound correlated with clinical grade and CT-visualized subarachnoid hemorrhage. J Neurosurg (1986) 0.98
In vivo somatostatin receptor imaging in medullary thyroid carcinoma. J Clin Endocrinol Metab (1993) 0.98
Fibrin glue in surgery: frequent development of inhibitors of bovine thrombin and human factor V. Br J Haematol (1993) 0.98
Localization of cholecystokinin A and cholecystokinin B-gastrin receptors in the human stomach. Gastroenterology (1997) 0.97
New specific radioligand for one subpopulation of brain somatostatin receptors. Life Sci (1985) 0.97
Neurotensin receptors in human neoplasms: high incidence in Ewing's sarcomas. Int J Cancer (1999) 0.97
Long-term follow-up of an epidemiologically defined cohort of patients with Tourette syndrome. J Child Neurol (2001) 0.97
Somatostatin inhibits the activity of adenylate cyclase in cultured human meningioma cells and stimulates their growth. J Clin Endocrinol Metab (1992) 0.97
Somatostatin receptors are present in small-cell but not in non-small-cell primary lung carcinomas: relationship to EGF-receptors. Int J Cancer (1990) 0.97
Potential role of somatostatin analogues in the treatment of cancer. Eur J Clin Invest (1987) 0.97
High density of somatostatin receptors in pituitary tumors from acromegalic patients. J Clin Endocrinol Metab (1984) 0.96
Evidence for two somatostatin-14 receptor types in rat brain cortex. Neurosci Lett (1984) 0.96
Somatostatin receptors and their subtypes in human tumors and in peritumoral vessels. Metabolism (1996) 0.96